21Shares XRP ETF
TOXRdata completeness 25%1 fiscal years on fileData notes: no data for concept 'revenue'; no data for concept 'operatingCashFlow'; no data for concept 'capex'; no data for concept 'cash'; no data for concept 'totalDebt'; no data for concept 'epsDiluted'; no data for concept 'interestExpense'; no data for concept 'incomeTaxExpense'; no data for concept 'pretaxIncome'
21Shares XRP ETF earns about -15% on equity. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2025 |
|---|---|
| Revenue | — |
| Net income | −$36M1 |
| Operating cash flow | — |
| Capital expenditure | — |
| Free cash flow (derived) | — |
| Total debt | — |
| Cash & equivalents | — |
| Diluted shares | — |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
It earned an average -15% on equity over 1 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Not enough history to read capital allocation.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2025-12-31 · accession 0001213900-26-036689 (NetIncomeLoss)